The global market for medical devices is $200 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° C to [...]
Ablation technologies of different types have in common their ability to produce a therapeutic effect on human tissue. Beyond this common ground, however, there are stark differences in the modalities. Consequently, ablation technologies have variable penetration of clinical applications, with use of specific modalities for specific clinical applications driven by factors such as the tissue [...]
Energy-based technologies and treatments exist for virtually all clinical specialties. Given the ability of these technologies, particularly ablation technologies, to very precisely destroy tissue, they have been strongly developed for cancer applications and much success has already been achieved in producing treatments that have low risk, short recovery times and good long term outcomes. Cost [...]
Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
The world market for energy-based devices was well in excess of $25 billion in 2008. This represents almost 14% of the total medical device market; however, the share varies from country to country, since ablation therapy is high-technology and fairly high-cost; in poorer economies low-cost medical products such as syringes and consumables account for a [...]
The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° [...]
The medical markets inthe Asia/Pacific region show enormous variations in size, due to differences in healthcare expenditure as well as the obvious differing population sizes. Although China and India have vastly greater populations than other countries in the region, it is the Japanese ablation market that takes the largest share of the global market, [...]
Below is a recent MedMarket Diligence report on Ablation Technologies. The report is described in detail at link.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities
· 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125
This report is a [...]
The major national markets in Western Europe for ablation technologies account for almost 12% of the global ablation market. Their share of the total medical device market is around 30%. Healthcare spending per capita is broadly similar across all the countries for which an example forecast (France) is provided below, ranging from approximately [...]
The energy-based medical device industry is led by a diverse group of companies, including small-to-medium pure-play companies specializing in ablation therapies and large multinationals whose interests encompass other classes of medical devices as well as ablation products. Key companies include Medtronic, St. Jude Medical, Varian Medical Systems, Boston Scientific (including Guidant), and Getinge.
In terms of [...]
Contact:
